Terms: = Head and neck cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
63 results:
1. Exploring Potential Biomarkers in Oesophageal cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract] [Full Text] [Related]
2. The cxcr4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis.
Chen P; Zhang YL; Zhang XL; Guo Y; Tang PP
Medicine (Baltimore); 2024 Apr; 103(14):e37681. PubMed ID: 38579048
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Value of WNT1, NOTCH1, PDGFRβ, and cxcr4 in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Anticancer Res; 2023 Feb; 43(2):591-602. PubMed ID: 36697060
[TBL] [Abstract] [Full Text] [Related]
4. CXCL12 is expressed by skeletal muscle cells in tongue oral squamous cell carcinoma.
Yorozu A; Sekiguchi S; Takasawa A; Okazaki F; Niinuma T; Kitajima H; Yamamoto E; Kai M; Toyota M; Hatanaka Y; Nishiyama K; Ogi K; Dehari H; Obata K; Kurose M; Kondo A; Osanai M; Miyazaki A; Takano K; Suzuki H
Cancer Med; 2023 Mar; 12(5):5953-5963. PubMed ID: 36300800
[TBL] [Abstract] [Full Text] [Related]
5. MT1X is an oncogene and indicates prognosis in ccRCC.
Ding Y; Fang J; Chen M; Xu Y; Liu N; Fang S; Xiang W; Chen R; Wu C; Yu H
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36149322
[TBL] [Abstract] [Full Text] [Related]
6. Poor prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
Zhang C; Cai Q; Ke J
Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
[TBL] [Abstract] [Full Text] [Related]
7. cxcr4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF-1α.
Wu X; Zhang H; Sui Z; Gao Y; Gong L; Chen C; Ma Z; Tang P; Yu Z
Cancer Sci; 2022 Mar; 113(3):926-939. PubMed ID: 34990040
[TBL] [Abstract] [Full Text] [Related]
8. Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/cxcr4 axis.
Zhao J; Li XD; Wang M; Song LN; Zhao MJ
Aging (Albany NY); 2021 May; 13(10):14078-14087. PubMed ID: 34015764
[TBL] [Abstract] [Full Text] [Related]
9. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/cxcr4 signaling.
Zheng X; Rui S; Wang XF; Zou XH; Gong YP; Li ZH
J Exp Clin Cancer Res; 2021 May; 40(1):157. PubMed ID: 33962657
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma.
Goto M; Shibahara Y; Baciu C; Allison F; Yeung JC; Darling GE; Liu M
Ann Surg Oncol; 2021 Sep; 28(9):4943-4951. PubMed ID: 33709176
[TBL] [Abstract] [Full Text] [Related]
11. Exposure to chewing tobacco promotes primary oral squamous cell carcinoma and regional lymph node metastasis by alterations of SDF1α/cxcr4 axis.
Ray S; Saha D; Alam N; Mitra Mustafi S; Mandal S; Sarkar A; Majumder B; Murmu N
Int J Exp Pathol; 2021 Apr; 102(2):80-92. PubMed ID: 33655604
[TBL] [Abstract] [Full Text] [Related]
12. Clinical association of cxcr4 in primary tumor of papillary thyroid cancer and response to iodine-131 treatment.
Sirakriengkrai K; Tepmongkol S; Keelawat S; Techavijit U
Nucl Med Commun; 2021 Apr; 42(4):396-401. PubMed ID: 33306632
[TBL] [Abstract] [Full Text] [Related]
13. Development of a Prognostic Signature Based on Autophagy-related Genes for head and neck Squamous Cell Carcinoma.
Jin Y; Qin X
Arch Med Res; 2020 Nov; 51(8):860-867. PubMed ID: 32948377
[TBL] [Abstract] [Full Text] [Related]
14. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic significance of cxcr4 expressions in patients with esophageal squamous cell carcinoma.
Yang X; Lu Q; Xu Y; Liu C; Sun Q
Pathol Res Pract; 2020 Jan; 216(1):152787. PubMed ID: 31859114
[TBL] [Abstract] [Full Text] [Related]
16. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract] [Full Text] [Related]
17. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.
Elhousiny M; Miller K; Ariyawadana A; Nimmo A
Clin Exp Metastasis; 2019 Dec; 36(6):481-492. PubMed ID: 31559586
[TBL] [Abstract] [Full Text] [Related]
18. cxcr4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
Jiang Q; Sun Y; Liu X
Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
[No Abstract] [Full Text] [Related]
19. Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and cxcr4 in squamous cell carcinoma of tongue and floor of the mouth.
Domingueti CB; Janini JB; Paranaíba LM; Lozano-Burgos C; Olivero P; González-Arriagada WA
Med Oral Patol Oral Cir Bucal; 2019 May; 24(3):e354-e363. PubMed ID: 31011147
[TBL] [Abstract] [Full Text] [Related]
20. cxcr4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract] [Full Text] [Related]
[Next]
